<p>Globus Medical（纽约证券交易所代码：GMED - 获取免费报告）在周五发布的报告中，皇家银行的投资分析师将其目标价格从 115.00 美元上调至 120.00 美元，Benzinga 报道。该券商目前对这家医疗设备公司的股票给予 “跑赢大盘” 的评级。皇家银行的目标价格意味着该公司股价有 51.72% 的潜在上涨空间。</p>
<p>其他几位分析师也对该股票发布了报告。Canaccord Genuity Group 将 Globus Medical 的目标价格从 105.00 美元上调至 112.00 美元，并在 1 月 9 日的报告中给予该公司 “买入” 评级。Needham &amp; Company LLC 将 Globus Medical 的目标价格从 114.00 美元上调至 117.00 美元，并在周五的报告中给予该公司 “买入” 评级。巴克莱将 Globus Medical 的目标价格从 118.00 美元上调至 123.00 美元，并在 2 月 25 日的报告中给予该公司 “增持” 评级。Piper Sandler 在 1 月 8 日的报告中重申了 “增持” 评级，并将 Globus Medical 的目标价格设定为 115.00 美元（上调自 90.00 美元）。最后，TD Cowen 在 1 月 27 日的报告中将 Globus Medical 的股票评级上调至 “强力买入”。两位股票研究分析师给予该股票 “强力买入” 评级，九位给予 “买入” 评级，五位给予 “持有” 评级。根据 MarketBeat 的数据，该公司的平均评级为 “适度买入”，平均目标价格为 106.36 美元。</p>
<p>获取 <strong>Globus Medical</strong> 警报：</p>
<p><strong>阅读我们关于 Globus Medical 的最新报告</strong></p>
<h2>Globus Medical 股票表现</h2>
<p>周五，NYSE GMED 的股票交易下跌 5.98 美元，跌至 79.09 美元。该公司交易了 2,551,746 股，较其平均交易量 1,233,959 股有所增加。Globus Medical 的 12 个月低点为 51.79 美元，12 个月高点为 101.40 美元。该公司的 50 日移动平均价格为 89.86 美元，200 日移动平均价格为 86.65 美元。该公司的市值为 107 亿美元，市盈率为 20.01，市盈增长比率为 2.09，贝塔值为 1.00。</p>
<p>Globus Medical（纽约证券交易所代码：GMED - 获取免费报告）最近在 5 月 7 日发布了季度财报。这家医疗设备公司报告本季度每股收益为 1.12 美元，超出市场共识预期的 0.92 美元，超出幅度为 0.20 美元。Globus Medical 的股本回报率为 12.57%，净利润率为 18.30%。该公司本季度的收入为 7.5985 亿美元，而分析师预期为 7.4035 亿美元。在去年同期，该公司每股收益为 0.68 美元。与去年同期相比，该公司的季度收入增长了 27.0%。Globus Medical 已将其 2026 财年的指导目标设定为每股收益 4.700-4.800 美元。研究分析师预计 Globus Medical 在当前财年将发布每股收益 4.46 美元。</p>
<h2>Globus Medical 的内部交易</h2>
<p>在相关消息中，执行副总裁 Kelly Huller 在 2 月 25 日的交易中出售了 20,000 股公司的股票。该股票以平均 94.50 美元的价格出售，总价值为 1,890,000.00 美元。此次出售在向 SEC 提交的文件中披露，相关文件可通过 SEC 网站访问。公司内部人士持有公司 18.38% 的股份。</p>
<h2>对 Globus Medical 的对冲基金看法</h2>
<p>机构投资者最近买入和卖出了该公司的股票。SBI 证券有限公司在第四季度将其在 Globus Medical 的持股增加了 98.2%。SBI 证券有限公司目前持有 337 股该医疗设备公司的股票，价值 29,000 美元，此前在上个季度增持了 167 股。Advisory Services Network LLC 在第三季度获得了 Globus Medical 的新头寸，价值约 26,000 美元。EverSource Wealth Advisors LLC 在第二季度将其在 Globus Medical 的持股增加了 74.3%。EverSource Wealth Advisors LLC 目前持有 462 股该医疗设备公司的股票，价值 27,000 美元，此前在上个季度增持了 197 股。Larson Financial Group LLC 在第四季度将其在 Globus Medical 的持股增加了 83.4%。Larson Financial Group LLC 目前持有 532 股该医疗设备公司的股票，价值 46,000 美元，此前在上个季度增持了 242 股。最后，First Horizon Corp 在第三季度获得了 Globus Medical 的新头寸，价值约 31,000 美元。95.16% 的股票由机构投资者和对冲基金持有。</p>
<h2>影响 Globus Medical 的关键故事</h2>
<p>以下是本周影响 Globus Medical 的关键新闻故事：</p>
<ul>
<li>积极情绪：第一季度业绩超出预期并上调 2026 财年每股收益指引——第一季度每股收益为 1.12 美元，超出市场共识，收入同比增长 27%；公司将 2026 财年每股收益指引设定为 4.70–4.80 美元（高于市场共识）。GMED 股票因第一季度业绩和收入超预期而上涨</li>
<li>积极情绪：分析师支持提升——Needham 将其目标价上调至 117 美元，并维持买入评级，表明分析师对公司持续信心，并认为当前股价有上涨空间。Benzinga</li>
<li>积极情绪：利润率扩张和盈利能力——公司报告净利润率改善（约 18.3%）和更高的股本回报率，强调了随着收入增长的经营杠杆。GlobeNewswire 新闻稿</li>
<li>中性情绪：完整电话会议/文字记录可用——管理层评论（财报电话会议/文字记录）可以提供关于手术量、积压订单和 2026 年节奏的详细信息；投资者应审查以获取执行信号。财报文字记录</li>
<li>中性情绪：覆盖与分析——多个媒体（Zacks、Seeking Alpha、SeattlePI、MarketBeat）发布了摘要和指标分析；这些内容细化了预期，但并未改变核心的超预期/指引故事。Zacks 第一季度覆盖</li>
<li>中性情绪：估值背景——该股票的市盈率约为 20 倍，PEG 约为 2.1；投资者在考虑在积极新闻发布后购买时，将权衡增长与倍数。MarketBeat 简介</li>
<li>消极情绪：尽管业绩超预期，股价仍下跌——这种差异表明短期获利了结或更广泛的市场/行业疲软；需监测日内流动情况以及在财报发布窗口后是否继续疲软。财报快照</li>
</ul>
<h2>关于 Globus Medical</h2>
<p>(获取免费报告)</p>
<p>Globus Medical, Inc NYSE: GMED 是一家领先的医疗器械公司，专注于脊柱和骨科应用的肌肉骨骼解决方案。公司成立于 2003 年，由 David C. Paul 创立，总部位于宾夕法尼亚州 Audubon，开发、制造和销售旨在治疗脊柱疾病和促进骨愈合的植入设备和外科器械。其产品组合涵盖了用于微创和开放手术的解决方案，包括椎间体融合设备、椎弓根螺钉系统和用于增强融合效果的生物制剂。</p>
<p>除了核心脊柱业务外，Globus Medical 还扩展到机器人和导航系统，以支持手术室的精确性和效率。</p>
<h2>另见</h2>
<ul>
<li>我们更看好的五只股票，胜过 Globus Medical</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUdNRUQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUdNRUQ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1000 美元在 Globus Medical 吗？</h2>
<p>在考虑 Globus Medical 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而 Globus Medical 并不在名单上。</p>
<p>虽然 Globus Medical 目前在分析师中获得中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

Globus医疗

<p>加拿大皇家银行将 Globus Medical（NYSE:GMED）的目标股价从 115.00 美元上调至 120.00 美元，维持 “跑赢大盘” 的评级。这个新目标暗示与前一交易日收盘价相比有 51.72% 的潜在上涨空间。其他分析师也提高了他们的目标股价，Canaccord Genuity 将其设定为 112.00 美元，Needham 则为 117.00 美元。该股票交易下跌至 79.09 美元，市值为 107 亿美元。Globus Medical 报告了强劲的季度收益，收入为 7.5985 亿美元，较去年同期增长 27%</p>

<p>Globus Medical (NYSE:GMED - Get Free Report) had its price objective hoisted by investment analysts at Royal Bank Of Canada from $115.00 to $120.00 in a report issued on Friday,Benzinga reports. The brokerage currently has an &#34;outperform&#34; rating on the medical device company's stock. Royal Bank Of Canada's target price points to a potential upside of 51.72% from the company's previous close.</p>
<div class="lb-trans"><p>Globus Medical（纽约证券交易所代码：GMED - 获取免费报告）在周五发布的报告中，皇家银行的投资分析师将其目标价格从 115.00 美元上调至 120.00 美元，Benzinga 报道。该券商目前对这家医疗设备公司的股票给予 “跑赢大盘” 的评级。皇家银行的目标价格意味着该公司股价有 51.72% 的潜在上涨空间。</p>
</div><p>Several other analysts have also issued reports on the stock. Canaccord Genuity Group boosted their price objective on shares of Globus Medical from $105.00 to $112.00 and gave the company a &#34;buy&#34; rating in a report on Friday, January 9th. Needham &amp; Company LLC boosted their price objective on shares of Globus Medical from $114.00 to $117.00 and gave the company a &#34;buy&#34; rating in a report on Friday. Barclays boosted their price objective on shares of Globus Medical from $118.00 to $123.00 and gave the company an &#34;overweight&#34; rating in a report on Wednesday, February 25th. Piper Sandler restated an &#34;overweight&#34; rating and issued a $115.00 price objective (up from $90.00) on shares of Globus Medical in a report on Thursday, January 8th. Finally, TD Cowen upgraded shares of Globus Medical to a &#34;strong-buy&#34; rating in a report on Tuesday, January 27th. Two equities research analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and five have given a Hold rating to the company. According to MarketBeat, the company has an average rating of &#34;Moderate Buy&#34; and an average price target of $106.36.</p>
<div class="lb-trans"><p>其他几位分析师也对该股票发布了报告。Canaccord Genuity Group 将 Globus Medical 的目标价格从 105.00 美元上调至 112.00 美元，并在 1 月 9 日的报告中给予该公司 “买入” 评级。Needham &amp; Company LLC 将 Globus Medical 的目标价格从 114.00 美元上调至 117.00 美元，并在周五的报告中给予该公司 “买入” 评级。巴克莱将 Globus Medical 的目标价格从 118.00 美元上调至 123.00 美元，并在 2 月 25 日的报告中给予该公司 “增持” 评级。Piper Sandler 在 1 月 8 日的报告中重申了 “增持” 评级，并将 Globus Medical 的目标价格设定为 115.00 美元（上调自 90.00 美元）。最后，TD Cowen 在 1 月 27 日的报告中将 Globus Medical 的股票评级上调至 “强力买入”。两位股票研究分析师给予该股票 “强力买入” 评级，九位给予 “买入” 评级，五位给予 “持有” 评级。根据 MarketBeat 的数据，该公司的平均评级为 “适度买入”，平均目标价格为 106.36 美元。</p>
</div><p>Get <strong>Globus Medical</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Globus Medical</strong> 警报：</p>
</div><p><strong>Read Our Latest Report on Globus Medical</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 Globus Medical 的最新报告</strong></p>
</div><h2>Globus Medical Stock Performance</h2>
<div class="lb-trans"><h2>Globus Medical 股票表现</h2>
</div><p>Shares of NYSE GMED traded down $5.98 during trading on Friday, hitting $79.09. 2,551,746 shares of the company were exchanged, compared to its average volume of 1,233,959. Globus Medical has a 12-month low of $51.79 and a 12-month high of $101.40. The company has a fifty day moving average price of $89.86 and a 200-day moving average price of $86.65. The firm has a market capitalization of $10.70 billion, a PE ratio of 20.01, a P/E/G ratio of 2.09 and a beta of 1.00.</p>
<div class="lb-trans"><p>周五，NYSE GMED 的股票交易下跌 5.98 美元，跌至 79.09 美元。该公司交易了 2,551,746 股，较其平均交易量 1,233,959 股有所增加。Globus Medical 的 12 个月低点为 51.79 美元，12 个月高点为 101.40 美元。该公司的 50 日移动平均价格为 89.86 美元，200 日移动平均价格为 86.65 美元。该公司的市值为 107 亿美元，市盈率为 20.01，市盈增长比率为 2.09，贝塔值为 1.00。</p>
</div><p>Globus Medical (NYSE:GMED - Get Free Report) last posted its quarterly earnings results on Thursday, May 7th. The medical device company reported $1.12 EPS for the quarter, topping the consensus estimate of $0.92 by $0.20. Globus Medical had a return on equity of 12.57% and a net margin of 18.30%.The business had revenue of $759.85 million for the quarter, compared to analyst estimates of $740.35 million. During the same quarter in the previous year, the firm earned $0.68 EPS. The company's quarterly revenue was up 27.0% compared to the same quarter last year. Globus Medical has set its FY 2026 guidance at 4.700-4.800 EPS. Research analysts anticipate that Globus Medical will post 4.46 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Globus Medical（纽约证券交易所代码：GMED - 获取免费报告）最近在 5 月 7 日发布了季度财报。这家医疗设备公司报告本季度每股收益为 1.12 美元，超出市场共识预期的 0.92 美元，超出幅度为 0.20 美元。Globus Medical 的股本回报率为 12.57%，净利润率为 18.30%。该公司本季度的收入为 7.5985 亿美元，而分析师预期为 7.4035 亿美元。在去年同期，该公司每股收益为 0.68 美元。与去年同期相比，该公司的季度收入增长了 27.0%。Globus Medical 已将其 2026 财年的指导目标设定为每股收益 4.700-4.800 美元。研究分析师预计 Globus Medical 在当前财年将发布每股收益 4.46 美元。</p>
</div><h2>Insider Transactions at Globus Medical</h2>
<div class="lb-trans"><h2>Globus Medical 的内部交易</h2>
</div><p>In related news, EVP Kelly Huller sold 20,000 shares of the business's stock in a transaction dated Wednesday, February 25th. The shares were sold at an average price of $94.50, for a total value of $1,890,000.00. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 18.38% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，执行副总裁 Kelly Huller 在 2 月 25 日的交易中出售了 20,000 股公司的股票。该股票以平均 94.50 美元的价格出售，总价值为 1,890,000.00 美元。此次出售在向 SEC 提交的文件中披露，相关文件可通过 SEC 网站访问。公司内部人士持有公司 18.38% 的股份。</p>
</div><h2>Hedge Funds Weigh In On Globus Medical</h2>
<div class="lb-trans"><h2>对 Globus Medical 的对冲基金看法</h2>
</div><p>Institutional investors have recently bought and sold shares of the company. SBI Securities Co. Ltd. grew its position in Globus Medical by 98.2% in the 4th quarter. SBI Securities Co. Ltd. now owns 337 shares of the medical device company's stock valued at $29,000 after acquiring an additional 167 shares in the last quarter. Advisory Services Network LLC acquired a new position in Globus Medical in the 3rd quarter valued at about $26,000. EverSource Wealth Advisors LLC grew its position in Globus Medical by 74.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 462 shares of the medical device company's stock valued at $27,000 after acquiring an additional 197 shares in the last quarter. Larson Financial Group LLC grew its position in Globus Medical by 83.4% in the 4th quarter. Larson Financial Group LLC now owns 532 shares of the medical device company's stock valued at $46,000 after acquiring an additional 242 shares in the last quarter. Finally, First Horizon Corp acquired a new position in Globus Medical in the 3rd quarter valued at about $31,000. 95.16% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>机构投资者最近买入和卖出了该公司的股票。SBI 证券有限公司在第四季度将其在 Globus Medical 的持股增加了 98.2%。SBI 证券有限公司目前持有 337 股该医疗设备公司的股票，价值 29,000 美元，此前在上个季度增持了 167 股。Advisory Services Network LLC 在第三季度获得了 Globus Medical 的新头寸，价值约 26,000 美元。EverSource Wealth Advisors LLC 在第二季度将其在 Globus Medical 的持股增加了 74.3%。EverSource Wealth Advisors LLC 目前持有 462 股该医疗设备公司的股票，价值 27,000 美元，此前在上个季度增持了 197 股。Larson Financial Group LLC 在第四季度将其在 Globus Medical 的持股增加了 83.4%。Larson Financial Group LLC 目前持有 532 股该医疗设备公司的股票，价值 46,000 美元，此前在上个季度增持了 242 股。最后，First Horizon Corp 在第三季度获得了 Globus Medical 的新头寸，价值约 31,000 美元。95.16% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Key Stories Impacting Globus Medical</h2>
<div class="lb-trans"><h2>影响 Globus Medical 的关键故事</h2>
</div><p>Here are the key news stories impacting Globus Medical this week:</p>
<div class="lb-trans"><p>以下是本周影响 Globus Medical 的关键新闻故事：</p>
</div><ul>
<li>Positive Sentiment: Q1 beat and raised FY26 EPS guide — Q1 EPS of $1.12 topped consensus and revenue rose 27% y/y; company set FY‑2026 EPS guidance to $4.70–4.80 (above consensus). GMED Stock Rises on Q1 Earnings &amp; Revenue Beat</li>
<li>Positive Sentiment: Analyst support lifted — Needham raised its price target (to $117) and maintained a Buy, signaling continued analyst confidence and added upside vs. the current share price. Benzinga</li>
<li>Positive Sentiment: Margin expansion and profitability — company reported improved net margin (~18.3%) and higher ROE, underlining operating leverage as revenue scales. GlobeNewswire press release</li>
<li>Neutral Sentiment: Full call/transcript available — management commentary (earnings call/transcript) can provide detail on procedure volumes, backlog and 2026 cadence; investors should review for execution signals. Earnings Transcript</li>
<li>Neutral Sentiment: Coverage &amp; analysis — multiple outlets (Zacks, Seeking Alpha, SeattlePI, MarketBeat) ran summaries and metric breakdowns; these refine expectations but don’t change the core beat/guidance story. Zacks Q1 coverage</li>
<li>Neutral Sentiment: Valuation context — the stock trades at roughly a ~20x P/E with PEG ~2.1; investors will weigh growth vs. multiple when deciding to buy after the run of positive news. MarketBeat profile</li>
<li>Negative Sentiment: Shares trading lower despite the beat — that divergence suggests short‑term profit taking or broader market/sector weakness; monitor intraday flow and whether weakness extends after the post‑earnings window. Earnings snapshot</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：第一季度业绩超出预期并上调 2026 财年每股收益指引——第一季度每股收益为 1.12 美元，超出市场共识，收入同比增长 27%；公司将 2026 财年每股收益指引设定为 4.70–4.80 美元（高于市场共识）。GMED 股票因第一季度业绩和收入超预期而上涨</li>
<li>积极情绪：分析师支持提升——Needham 将其目标价上调至 117 美元，并维持买入评级，表明分析师对公司持续信心，并认为当前股价有上涨空间。Benzinga</li>
<li>积极情绪：利润率扩张和盈利能力——公司报告净利润率改善（约 18.3%）和更高的股本回报率，强调了随着收入增长的经营杠杆。GlobeNewswire 新闻稿</li>
<li>中性情绪：完整电话会议/文字记录可用——管理层评论（财报电话会议/文字记录）可以提供关于手术量、积压订单和 2026 年节奏的详细信息；投资者应审查以获取执行信号。财报文字记录</li>
<li>中性情绪：覆盖与分析——多个媒体（Zacks、Seeking Alpha、SeattlePI、MarketBeat）发布了摘要和指标分析；这些内容细化了预期，但并未改变核心的超预期/指引故事。Zacks 第一季度覆盖</li>
<li>中性情绪：估值背景——该股票的市盈率约为 20 倍，PEG 约为 2.1；投资者在考虑在积极新闻发布后购买时，将权衡增长与倍数。MarketBeat 简介</li>
<li>消极情绪：尽管业绩超预期，股价仍下跌——这种差异表明短期获利了结或更广泛的市场/行业疲软；需监测日内流动情况以及在财报发布窗口后是否继续疲软。财报快照</li>
</ul>
</div><h2>About Globus Medical</h2>
<div class="lb-trans"><h2>关于 Globus Medical</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Globus Medical, Inc NYSE: GMED is a leading medical device company specializing in musculoskeletal solutions for spine and orthopaedic applications. Founded in 2003 by David C. Paul and headquartered in Audubon, Pennsylvania, the company develops, manufactures and markets implantable devices and surgical instruments designed to treat spinal disorders and promote bone healing. Its product portfolio encompasses solutions for minimally invasive and open surgical procedures, including interbody fusion devices, pedicle screw systems, and biologics used to enhance fusion outcomes.</p>
<div class="lb-trans"><p>Globus Medical, Inc NYSE: GMED 是一家领先的医疗器械公司，专注于脊柱和骨科应用的肌肉骨骼解决方案。公司成立于 2003 年，由 David C. Paul 创立，总部位于宾夕法尼亚州 Audubon，开发、制造和销售旨在治疗脊柱疾病和促进骨愈合的植入设备和外科器械。其产品组合涵盖了用于微创和开放手术的解决方案，包括椎间体融合设备、椎弓根螺钉系统和用于增强融合效果的生物制剂。</p>
</div><p>In addition to its core spine business, Globus Medical has expanded into robotics and navigation systems to support precision and efficiency in the operating room.</p>
<div class="lb-trans"><p>除了核心脊柱业务外，Globus Medical 还扩展到机器人和导航系统，以支持手术室的精确性和效率。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Globus Medical</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过 Globus Medical</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUdNRUQ" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=GMED"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Globus Medical Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Globus Medical 吗？</h2>
</div><p>Before you consider Globus Medical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Globus Medical 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globus Medical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而 Globus Medical 并不在名单上。</p>
</div><p>While Globus Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Globus Medical 目前在分析师中获得中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Globus Medical (NYSE:GMED) Given New $120.00 Price Target at Royal Bank Of Canada

Market Beat

加拿大皇家银行

加拿大帝国商业银行

Bank7

Blaize

Zenas Biopharma

Zimmer Biomet

Nano Labs

Genuit Group PLC

凯雷集团

Capital Group New Geography Equity ETF

CF实业

Landbridge Co LLC

New England Real Asso

Newton Golf Company

巴克莱银行

Piper Sandler Cos

Toronto Dominion Bank

蒙特利尔银行

美国股票 MarketBeta ETF - Goldman Sachs

MarketWise

Value Line

SBI Holdings, Inc.

SBI Insurance Group Co., Ltd.

San Holdings, Inc. (Japan)

Advantage Solutions

PMV Adaptive Risk Parity ETF

Network 1 Tech

能源方案

Everquote

WealthNavi, Inc.

莱克兰金融

Clarkson PLC

Donnelley Financial Solution

第一地平线

BLAIZE HOLDINGS INC C/WTS 13/01/2030 (TO PUR COM)

ADVANTAGE SOLUTIONS INC C/WTS 28/10/2025(TO PUR COM)

FIRST HORIZON CORPORATION 6.50% DEP SHS REP 1/4000 PER PFD SER E

FIRST HORIZON CORPORATION DEP SHS REP 1/400 NON CUM PER PFD SER C

FIRST HORIZON CORPORATION DEP SHS REP 1/400 NON CUM PER PFD SER B

FIRST HORIZON CORPORATION DEP SH REP 1/4000 INT NON CUM PFD H WI

FIRST HORIZON CORPORATION DEP SHS REPSTG 1/4000TH PERP PFD SER F

Globus Medical（纽约证券交易所代码：GMED）被加拿大皇家银行设定了新的 120.00 美元目标价